Teams

TeamS is a Japanese biotechnology company focused on the research and development of innovative therapeutics based on sulfur biology. The company leverages its proprietary platform to target enzymes involved in the metabolism of reactive sulfur species, such as cystathionine gamma-lyase and cystathionine beta-synthase. Their primary goal is to address unmet medical needs in metabolic disorders and vascular diseases, including cystinuria and homocystinuria. By modulating sulfur-related pathways, TeamS aims to develop first-in-class small molecule treatments for conditions characterized by oxidative stress and metabolic dysfunction.